We are live on
!
Find out more
AA
ALPS Advisors Portfolio holdings
AUM
$21.3B
1-Year Est. Return
21.71%
This Fund
S&P 500
This Quarter
Est. Return
+4%
1 Year Est. Return
+21.71%
3 Year Est. Return
+77.63%
5 Year Est. Return
+121.1%
10 Year Est. Return
+198.29%
AUM
$10.6B
AUM Growth
+$284M
(+2.8%)
Cap. Flow
+$73.1M
Cap. Flow
% of AUM
0.69%
Top 10 Holdings %
Top 10 Hldgs %
48.98%
Holding
1,222
New
192
Increased
357
Reduced
489
Closed
182
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Delek Logistics
DKL
|
+$68.3M |
| 2 |
MRSH
Marsh
MRSH
|
+$22.7M |
| 3 |
S&P Global
SPGI
|
+$21.3M |
| 4 |
T. Rowe Price
TROW
|
+$20.9M |
| 5 |
Cheniere Energy
CQP
|
+$16.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Hess Midstream
HESM
|
+$39.6M |
| 2 |
Plains All American Pipeline
PAA
|
+$22.1M |
| 3 |
Lockheed Martin
LMT
|
+$18.8M |
| 4 |
Procter & Gamble
PG
|
+$16.2M |
| 5 |
First Solar
FSLR
|
+$16.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 62.63% |
| 2 | Technology | 6.2% |
| 3 | Consumer Discretionary | 4.28% |
| 4 | Healthcare | 4.08% |
| 5 | Financials | 3.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALBO
1001
DELISTED
Albireo Pharma Inc
ALBO
| $208K | ﹤0.01% |
10,748
-864
| -7% | -$17.9K |
|
|
CNTA
1002
DELISTED
Centessa Pharmaceuticals
CNTA
| $207K | ﹤0.01% |
51,503
-4,282
| -8% | -$19.6K |
|
1003
O-I Glass
OI
$1.39B
| $199K | ﹤0.01% |
15,336
-1,869
| -11% | -$25.3K |
|
|
KALV
1004
DELISTED
KalVista Pharmaceuticals
KALV
| $195K | ﹤0.01% |
13,433
-1,128
| -8% | -$15.8K |
|
1005
Identive
INVE
$64.6M
| $188K | ﹤0.01% |
14,995
-1,942
| -11% | -$26.6K |
|
1006
ADC Therapeutics
ADCT
$146M
| $186K | ﹤0.01% |
38,571
-6,992
| -15% | -$50.6K |
|
1007
Invivyd
IVVD
$180M
| $186K | ﹤0.01% |
59,405
-5,690
| -9% | -$22.7K |
|
|
NBP
1008
NovaBridge Biosciences American Depositary Shares
NBP
$205M
| $181K | ﹤0.01% |
45,137
-3,888
| -8% | -$29.5K |
|
1009
BioXcel Therapeutics
BTAI
$26.2M
| $180K | ﹤0.01% |
953
-84
| -8% | -$19.5K |
|
1010
MiMedx Group
MDXG
$626M
| $178K | ﹤0.01% |
62,007
-5,233
| -8% | -$18.6K |
|
|
CNCE
1011
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $176K | ﹤0.01% |
26,197
-468
| -2% | -$2.84K |
|
1012
Tango Therapeutics
TNGX
$4.34B
| $174K | ﹤0.01% |
48,071
-4,074
| -8% | -$17.4K |
|
1013
SiriusXM
SIRI
$10B
| $171K | ﹤0.01% |
2,995
-421
| -12% | -$26.5K |
|
1014
Aldeyra Therapeutics
ALDX
$91.7M
| $170K | ﹤0.01% |
31,813
-2,768
| -8% | -$16.6K |
|
|
AFMD
1015
DELISTED
Affimed
AFMD
| $164K | ﹤0.01% |
7,964
-693
| -8% | -$19.3K |
|
|
WHWK
1016
Whitehawk Therapeutics
WHWK
$183M
| $163K | ﹤0.01% |
11,509
-914
| -7% | -$12K |
|
1017
MoonLake Immunotherapeutics
MLTX
$1.59B
| $160K | ﹤0.01% |
20,144
-11,116
| -36% | -$78.6K |
|
1018
Host Hotels & Resorts
HST
$16.8B
| $159K | ﹤0.01% |
+10,019
| New | +$175K |
|
1019
Arbutus Biopharma
ABUS
$865M
| $156K | ﹤0.01% |
81,878
-6,346
| -7% | -$14.9K |
|
|
VXRT
1020
DELISTED
Vaxart
VXRT
| $151K | ﹤0.01% |
69,043
-5,971
| -8% | -$20.6K |
|
1021
4D Molecular Therapeutics
FDMT
$526M
| $142K | ﹤0.01% |
17,663
-1,492
| -8% | -$13.5K |
|
1022
Transocean
RIG
$5.92B
| $127K | ﹤0.01% |
51,337
-6,138
| -11% | -$19.6K |
|
|
ZYXI
1023
DELISTED
Zynex
ZYXI
| $124K | ﹤0.01% |
13,709
-2,146
| -14% | -$18.8K |
|
|
LIAN
1024
DELISTED
LianBio American Depositary Shares
LIAN
| $116K | ﹤0.01% |
58,490
-5,738
| -9% | -$13.7K |
|
1025
SunCoke Energy
SXC
$757M
| $114K | ﹤0.01% |
19,704
-1,644
| -8% | -$11K |
|
Similar funds
PAG
MMH
IC
DSA
VARA
SC
CB
ALPS Advisors's Q3 2022 Portfolio in Review
As of Q3 2022, ALPS Advisors held 1,222 positions worth $10.6B, up 2.8% from $10.3B the previous quarter. Its ten largest holdings account for 49% of the portfolio.
ALPS Advisors's Q3 2022 filing shows 192 new, 357 increased, 489 reduced and 182 closed positions. Its largest new stake was Delek Logistics: 1,253,434 shares worth $63.9M. The largest sale was Hess Midstream, an estimated $39.6M.
By sector, the portfolio is most concentrated in Energy at 63% of assets, up from 60% a quarter earlier, followed by Technology and Consumer Discretionary.
- ALPS Advisors's largest Q3 2022 buy was Delek Logistics: 1,253,434 shares worth $63.9M.
- ALPS Advisors added most to Marsh in Q3 2022, an estimated $22.7M increase.
- ALPS Advisors's biggest Q3 2022 reduction was Hess Midstream, cutting an estimated $39.6M.
- ALPS Advisors fully exited Allstate in Q3 2022, selling an estimated $5.07M.
- ALPS Advisors's ten largest holdings make up 49% of its $10.6B portfolio in Q3 2022.
- ALPS Advisors opened 192 new positions and closed 182 in Q3 2022.
- ALPS Advisors's portfolio value rose 2.8% quarter-over-quarter to $10.6B.
Based on ALPS Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.